Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA) is a blank-check company sponsored by Sarissa Capital Management, the healthcare-focused activist investment firm founded by Alex Denner. The SPAC completed its IPO in 2021 and targets opportunities in the biopharmaceutical and broader healthcare sector, reflecting the sponsor's deep domain expertise in life sciences. The April 2022 amended annual report on Form 10-K/A, filed under accession number 0001193125-22-093859, represents part of the company's public disclosure record during its search period. For full filing history, deal timelines, sponsor background, and real-time status updates on SRSA and hundreds of other SPACs, sign up for SpacDesk at spacdesk.com.